Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 32OTHER 22NETWORK 1FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 23Breast Neoplasms 23Carcinoma, Non-Small-Cell Lung 16Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Multiple Myeloma 14Colorectal Neoplasms 12Lymphoma 10Neoplasms 9Lung Neoplasms 9Melanoma 8Leukemia, Myeloid, Acute 8Pancreatic Neoplasms 7Lymphoma, Non-Hodgkin 7Leukemia, Biphenotypic, Acute 6Burkitt Lymphoma 6Squamous Cell Carcinoma of Head and Neck 5Head and Neck Neoplasms 5Ependymoma 5Endometrial Neoplasms 5Colonic Neoplasms 5Wilms Tumor 4Rectal Neoplasms 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 4Ovarian Neoplasms 4Osteosarcoma 4Neoplasm Metastasis 4Medulloblastoma 4Malignant Solid Neoplasm 4Lymphoma, Mantle-Cell 4

Interventions

Gemcitabine 1Docetaxel 1BCG Vaccine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Non-Muscle Invasive Bladder Neoplasms × 90 days × Clear all
NCT05538663 2026-05-05

BRIDGE

Eastern Cooperative Oncology Group

Phase 3 Active not recruiting
870 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡